{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:27:16Z","timestamp":1792794436696,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"43","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000901","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DUK"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JDRF-CCTN"},{"name":"Juvenile Diabetes Research Fund\u2014Canadian Clinical Trials Network"},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Leducq Trans-Atlantic Network of Excellence","id":[{"id":"https:\/\/ror.org\/01czwga19","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>High-density lipoprotein (HDL) function may be altered in patients with chronic disease, transforming the particle from a beneficial vasoprotective molecule to a noxious pro-inflammatory equivalent. Adolescents with Type 1 diabetes often have elevated HDL, but its vasoprotective properties and relationship to endothelial function have not been assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Seventy adolescents with Type 1 diabetes (age 10\u201317 years) and 30 age-matched healthy controls supplied urine samples for the measurement of early renal dysfunction (albumin:creatinine ratio; ACR), blood samples for the assessment of cardiovascular risk factors (lipid profiles, HDL functionality, glycaemic control, and inflammatory risk score), and had their conduit artery endothelial function tested using flow-mediated dilation (FMD). HDL-c levels (1.69\u2009\u00b1\u20090.41 vs. 1.44\u2009\u00b1\u20090.29mmol\/L; P\u2009&amp;lt;\u20090.001), and glycated haemoglobin (HbA1c) (8.4\u2009\u00b1\u20091.2 vs. 5.4\u2009\u00b1\u20090.2%; P\u2009&amp;lt;\u20090.001) were increased in all patients compared with controls. However, increased inflammation and HDL dysfunction were evident only in patients who also had evidence of early renal dysfunction (mean\u2009\u00b1\u2009standard deviation for high-ACR vs. low-ACR and healthy controls: inflammatory risk score 11.3\u2009\u00b1\u20092.5 vs. 9.5\u2009\u00b1\u20092.4 and 9.2\u2009\u00b1\u20092.4, P\u2009&amp;lt;\u20090.01; HDL-mediated nitric-oxide bioavailability 38.0\u2009\u00b1\u20098.9 vs. 33.3\u2009\u00b1\u20097.3 and 25.0\u2009\u00b1\u20097.7%, P\u2009&amp;lt;\u20090.001; HDL-mediated superoxide production 3.71\u2009\u00b1\u20093.57 vs. 2.11\u2009\u00b1\u20093.49 and 1.91\u2009\u00b1\u20092.47nmol O2 per 250\u00a0000 cells, P\u2009&amp;lt;\u20090.05). Endothelial function (FMD) was impaired only in those who had both a high inflammatory risk score and high levels of HDL-c (P\u2009&amp;lt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Increased levels of HDL-c commonly observed in individuals with Type 1 diabetes may be detrimental to endothelial function when accompanied by renal dysfunction and chronic inflammation.<\/jats:p>\n                    <jats:p\/>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehz114","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T07:56:27Z","timestamp":1550476587000},"page":"3559-3566","source":"Crossref","is-referenced-by-count":55,"title":["Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation"],"prefix":"10.1093","volume":"40","author":[{"given":"Scott T","family":"Chiesa","sequence":"first","affiliation":[{"name":"Vascular Physiology Unit, UCL Institute of Cardiovascular Science , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Charakida","sequence":"additional","affiliation":[{"name":"Vascular Physiology Unit, UCL Institute of Cardiovascular Science , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"McLoughlin","sequence":"additional","affiliation":[{"name":"Vascular Physiology Unit, UCL Institute of Cardiovascular Science , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen C","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Vascular Physiology Unit, UCL Institute of Cardiovascular Science , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgiopoulos","sequence":"additional","affiliation":[{"name":"University of Athens, Hippokratio Hospital 1st Cardiology Clinic, , Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Motran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto , Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesmino","family":"Elia","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto , Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Loredana","family":"Marcovecchio","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Cambridge , Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B","family":"Dunger","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Cambridge , Cambridge, UK"},{"name":"Institute of Metabolic Science, University of Cambridge , Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Neil","family":"Dalton","sequence":"additional","affiliation":[{"name":"WellChild Laboratory, St. Thomas\u2019 Hospital, King\u2019s College London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Daneman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto , Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sochett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto , Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid H","family":"Mahmud","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital for Sick Children, University of Toronto , Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Deanfield","sequence":"additional","affiliation":[{"name":"Vascular Physiology Unit, UCL Institute of Cardiovascular Science , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"2022102607535905200_ehz114-B1","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2337\/db10-0862","article-title":"Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes","volume":"59","author":"Secrest","year":"2010","journal-title":"Diabetes"},{"key":"2022102607535905200_ehz114-B2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"2022102607535905200_ehz114-B3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jpeds.2009.11.011","article-title":"Prevalence of increased arterial stiffness in children with type 1 diabetes mellitus differs by measurement site and sex: the SEARCH for Diabetes in Youth Study","volume":"156","author":"Urbina","year":"2010","journal-title":"J Pediatr"},{"key":"2022102607535905200_ehz114-B4","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2337\/dc14-0700","article-title":"Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT)","volume":"37","author":"Maftei","year":"2014","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","article-title":"Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis","volume":"168","author":"Ras","year":"2013","journal-title":"Int J Cardiol"},{"key":"2022102607535905200_ehz114-B6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejvs.2009.01.015","article-title":"Early endothelial dysfunction in young type 1 diabetics","volume":"37","author":"Hurks","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2022102607535905200_ehz114-B7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2337\/dc10-2134","article-title":"Impaired endothelial function in preadolescent children with type 1 diabetes","volume":"34","author":"Babar","year":"2011","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2017.10.018","article-title":"HDL functionality in type 1 diabetes","volume":"267","author":"Ganjali","year":"2017","journal-title":"Atherosclerosis"},{"key":"2022102607535905200_ehz114-B9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2337\/diab.27.11.1078","article-title":"Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations","volume":"27","author":"Nikkil\u00e4","year":"1978","journal-title":"Diabetes"},{"key":"2022102607535905200_ehz114-B10","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.2337\/diabetes.51.11.3300","article-title":"Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"key":"2022102607535905200_ehz114-B11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1651-2227.1999.tb00989.x","article-title":"Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus","volume":"88","author":"Hayashibe","year":"1999","journal-title":"Acta Paediatr"},{"key":"2022102607535905200_ehz114-B12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"2022102607535905200_ehz114-B13","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","article-title":"Type 1 diabetes and coronary artery disease","volume":"29","author":"Orchard","year":"2006","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1194\/jlr.M059089","article-title":"Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity","volume":"56","author":"Vaisar","year":"2015","journal-title":"J Lipid Res"},{"key":"2022102607535905200_ehz114-B15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/qjmed\/hci136","article-title":"Reverse cholesterol transport and cholesterol efflux in atherosclerosis","volume":"98","author":"Ohashi","year":"2005","journal-title":"QJM"},{"key":"2022102607535905200_ehz114-B16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.108.836346","article-title":"Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy","volume":"121","author":"Sorrentino","year":"2010","journal-title":"Circulation"},{"key":"2022102607535905200_ehz114-B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2015.03.058","article-title":"Structural and functional changes in HDL with low grade and chronic inflammation","volume":"188","author":"O\u2019Neill","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022102607535905200_ehz114-B18","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1681\/ASN.2013111212","article-title":"HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype","volume":"25","author":"Shroff","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2022102607535905200_ehz114-B19","first-page":"3007","article-title":"Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk","volume":"36","author":"Zewinger","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102607535905200_ehz114-B20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cyto.2017.07.013","article-title":"Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes","volume":"99","author":"Sochett","year":"2017","journal-title":"Cytokine"},{"key":"2022102607535905200_ehz114-B21","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1371\/journal.pone.0111131","article-title":"The urinary cytokine\/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes","volume":"9","author":"Har","year":"2014","journal-title":"PLoS One"},{"key":"2022102607535905200_ehz114-B22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1464-5491.2006.02047.x","article-title":"Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria?","volume":"24","author":"Dunger","year":"2007","journal-title":"Diabet Med"},{"key":"2022102607535905200_ehz114-B23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2337\/dc13-1634","article-title":"Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments","volume":"37","author":"Marcovecchio","year":"2014","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0022-2275(20)32200-8","article-title":"A low temperature flotation method to rapidly isolate lipoproteins from plasma","volume":"39","author":"Tong","year":"1998","journal-title":"J Lipid Res"},{"key":"2022102607535905200_ehz114-B25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.atherosclerosis.2015.06.005","article-title":"Reproducibility and biological variability of HDL\u2019s vascular functional assays","volume":"241","author":"O\u2019Neill","year":"2015","journal-title":"Atherosclerosis"},{"key":"2022102607535905200_ehz114-B26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2008.02.044","article-title":"Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation","volume":"51","author":"Donald","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022102607535905200_ehz114-B27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc14-1848","article-title":". Cardiac autonomic dysfunction is associated with high-risk albumin-to-creatinine ratio in young adolescents with type 1 diabetes in AdDIT (adolescent type 1 diabetes cardio-renal interventional trial)","volume":"38","author":"Cho","year":"2015","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2215\/CJN.04180510","article-title":"Which creatinine and cystatin C equations can be reliably used in children?","volume":"6","author":"Bacchetta","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022102607535905200_ehz114-B29","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102607535905200_ehz114-B30","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102607535905200_ehz114-B31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/dc10-1177","article-title":"High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol","volume":"34","author":"Salardi","year":"2011","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/diacare.29.01.06.dc05-1583","article-title":"Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes","volume":"29","author":"Molitch","year":"2006","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B33","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2337\/dc06-0264","article-title":"Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes: response to Molitch et al","volume":"29","author":"Wierusz-Wysocka","year":"2006","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jacl.2011.06.011","article-title":"High-density lipoprotein cholesterol in diabetes: is higher always better?","volume":"5","author":"Costacou","year":"2011","journal-title":"J Clin Lipidol"},{"key":"2022102607535905200_ehz114-B35","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.2337\/dc07-0030","article-title":"HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes","volume":"30","author":"Groop","year":"2007","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.18388\/abp.2015_1209","article-title":"Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus","volume":"63","author":"Craciun","year":"2016","journal-title":"Acta Biochim Pol"},{"key":"2022102607535905200_ehz114-B37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bfopcu.2017.05.002","article-title":"Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM","volume":"55","author":"Omar","year":"2017","journal-title":"Bull Fac Pharmacy, Cairo Univ"},{"key":"2022102607535905200_ehz114-B38","doi-asserted-by":"crossref","first-page":"85.","DOI":"10.1186\/s12933-017-0570-2","article-title":"Reduced HDL function in children and young adults with type 1 diabetes","volume":"16","author":"Heier","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"2022102607535905200_ehz114-B39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/diacare.22.3.495","article-title":"Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group","volume":"22","author":"Schultz","year":"1999","journal-title":"Diabetes Care"},{"key":"2022102607535905200_ehz114-B40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.metabol.2016.06.008","article-title":"Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus","volume":"65","author":"Manjunatha","year":"2016","journal-title":"Metabolism"},{"key":"2022102607535905200_ehz114-B41","doi-asserted-by":"crossref","first-page":"e002270","DOI":"10.1161\/JAHA.115.002270","article-title":"Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis","volume":"4","author":"Matsuzawa","year":"2015","journal-title":"J Am Heart Assoc"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/43\/3559\/46638106\/eurheartj_40_43_3559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/43\/3559\/46638106\/eurheartj_40_43_3559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T03:54:45Z","timestamp":1666756485000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/43\/3559\/5376681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":41,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2019,3,12]]},"published-print":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehz114","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,14]]},"published":{"date-parts":[[2019,3,12]]}}}